Abstract
The recent cloning of the complementary DNAs and/or genes for several receptors linked to guanine nucleotide regulatory proteins including the adrenergic receptors (α1, α2A, α2B, β1, β2)1–7 several subtypes of the muscarinic cholinergic receptors8,9, and the visual 'receptor' rhodopsin10 has revealed considerable similarity in the primary structure of these proteins. In addition, all of these proteins contain seven putative transmembrane α-helices. We have previously described a genomic clone, G-21, isolated by cross-hybridization at reduced stringency with a full length β2- adrenergic receptor probe11. This clone contains an intronless gene which, because of its striking sequence resemblance to the adrenergic receptors, is presumed to encode a G-protein-coupled receptor. Previous attempts to identify this putative receptor by expression studies have failed. We now report that the protein product of the genomic clone, G21, transiently expressed in monkey kidney cells has all the typical ligand-binding characteristics of the 5-hydroxytryptamine (5-HT1A) receptor.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dixon, R. A. F. et al. Nature 321, 75–79 (1986).
Yarden, Y. et al. Proc. natn. Acad. Sci. U.S.A. 83, 6795–6799 (1986).
Kobilka, B. K. et al. Proc. natn. Acad. Sci. U.S.A. 84, 46–50 (1987).
Frielle, T. et al. Proc. natn. Acad. Sci. U.S.A. 84, 7920–7924 (1987).
Kobilka, B. K. et al. Science 238, 650–656 (1987).
Cotecchia S. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Regan, J. W. et al. Proc. natn. Acad. Sci. U.S.A. (in the press).
Kubo, T. et al. Nature 323, 411–416 (1986).
Kubo, T. et al. FEBS Lett. 209, 367–372 (1986).
Nathans, J. & Hogness, D. S. Proc. natn. Acad. Sci. U.S.A. 81, 4851–4855 (1984).
Kobilka, B. K. et al. Nature 329, 75–79 (1987).
Bradley, P. B. et al. Neuropharmacol. 25, 563–575 (1987).
Göthert, M. & Schlicker, E. J. Cardiovasc. Pharmacol 10(suppl. 10), S3–S7 (1987).
Peroutka, S. J. ISI Atlas of Sei.: Pharmac. 2, 1–4 (1988).
Leysen, J. E. Neuromethods, Neuropharmacology II: Drugs as Tools in Neurotransmilter Research (eds Boulton, A. A., Baker, G. B. & Jourio, A. V.) (Humana, Clifton, in press).
Cullen, B. R. Meth. Enzym. 152, 684–704 (1987).
Hoyer, D., Engel, G. & Kalkman, H. O. Eur. J. Pharmac. 118, 1–12 (1985).
Hoyer, D., Engel, G. & Kalkman, H. O. Eur. J. Pharmac. 118, 13–23 (1985).
Gozlan, H., Mestikawy, S., Pichat, L., Glowinsky, G. & Hamon, M. Nature 305, 140–142 (1983).
Sills, M. A., Wolfe, B. B. & Frazer, A. Molec. Pharmac. 26, 10–18 (1984).
Hall, M. D. et al. J. Neurochem. 44, 1685–1696 (1985).
Schlegel, J. R. & Peroutka, S. J. Biochem. Pharmac. 35, 1943–1949 (1986).
Shenker, A. et al. Eur. J. Pharmac. 109, 427–429 (1985).
Markstein, R., Hoyer, D. & Engel, G. Naunyn-Schmiedebergs Archs Pharmak. 333, 335–341 (1986).
Weiss, S., Sebben, M., Kempe, D. & Bockaert, J. Eur. J. Pharmacol. 120, 227–230 (1986).
De Vivo, M. & Maayani, S. J. Pharmac. exp. The. 238, 248–253 (1986).
Bockaert, J. A. et al. Naunyn-Schmiedebergs Arch. Pharmak. 335, 588–592 (1987).
Colino, A. & Halliwell, J. V. Nature 328, 73–77 (1987).
Andrade, R. & Nicoll, R. A. J. Physiol., Lond. 394, 99–124 (1987).
Kobilka, B. K. et al. Science 240, 1310–1316 (1988).
Sternberg, E. M., Wedner, J. H., Leung, M. K. & Parker, C. W. J. lmmun. 138, 4360–4365 (1987).
Hellstrand, K. & Hermodsson, S. J. Immun. 139, 869–875 (1987).
DeLean, A., Hancock, A. A. & Lefkowitz, R. J. Molec. Pharmac. 21, 5–16 (1982).
Chirgwin, J. M., Przybyla, A. E., McDonald, R. J. & Rutter, W. J. Biochemistry 18, 5294–5299 (1979).
McMaster, G. K. & Carmichael, G. C. Proc. natn. Acad. Sci. U.S.A. 74, 4835–4838 (1977).
Azis, N. & Munro, H. N. Nucleic Acids Res. 14, 915–927 (1986).
Gozlan, H. et al. J. Receptor Res. 7, 195–221 (1987).
Julius, D. et al. Science 241, 558–564 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fargin, A., Raymond, J., Lohse, M. et al. The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor. Nature 335, 358–360 (1988). https://doi.org/10.1038/335358a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/335358a0
This article is cited by
-
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment
Psychopharmacology (2017)
-
The Camerino symposium series (1978–2013): a privileged observatory of receptorology development
In Silico Pharmacology (2013)
-
Studies of a ubiquitous receptor family
Nature (2012)
-
Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness
Molecular Brain (2011)
-
[18F]F15599, a novel 5-HT1A receptor agonist, as a radioligand for PET neuroimaging
European Journal of Nuclear Medicine and Molecular Imaging (2010)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.